The influence of health status, age, and race on screening mammography in elderly women

被引:63
作者
Bynum, JPW
Braunstein, JB
Sharkey, P
Haddad, K
Wu, AW
机构
[1] Dartmouth Coll Sch Med, Dept Internal Med, Hanover, NH USA
[2] Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Cardiol, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[5] Loyola Coll, Sellinger Sch Business, Dept Informat Syst & Operat Management, Baltimore, MD USA
关键词
D O I
10.1001/archinte.165.18.2083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Screening mammography is controversial for elderly women because of an absence of efficacy data. Decisions to screen are based on individualized assessment of risks and benefits. Our objective was to determine how screening mammography varies by age and race when adjusted for propensity to die. Methods: In a retrospective cohort study, rates of screening mammogram performed in 2000-2001 based on claims, adjusted for propensity to die in 2000, were determined for a nationally representative 5% random sample of fernale fee-for-service Medicare beneficiaries 65 years and older in (N = 722310). Results: The overall rate of screening was 39%. When stratified into quintiles by propensity to die, 2-year rates ranged from 61% in the lowest-risk group to 5% in the highest-risk group. In analyses stratified by age and adjusted for propensity to die, 42% of women aged 65 to 69 years were screened, declining to 26% of women 85 years and older (P <.001). Adjusted screening rates for white women, black women, and women of other races were 40%, 30%, and 25%, respectively (P <.001). Thus, among women with similar health status, the youngest women were 1.61 times more likely to be screened compared with the oldest; compared with black women and women of other races, white women were 1.38 and 1.60 times, respectively, more likely to be screened. Conclusions: Decisions to screen for breast cancer are related not only to health status but also to age and race. Underuse and overuse of screening mammography likely occurs owing to age- and race-associated decision making. Assessment of life expectancy may more accurately identify women who could benefit from screening.
引用
收藏
页码:2083 / 2088
页数:6
相关论文
共 46 条
[1]  
*AM GER SOC, 2004, BREAST CANC SCREEN O
[2]  
Arday SL, 2000, HEALTH CARE FINANC R, V21, P107
[3]   Measuring underuse of necessary care among elderly Medicare beneficiaries using inpatient and outpatient claims [J].
Asch, SM ;
Sloss, EEM ;
Hogan, C ;
Brook, RH ;
Kravitz, RL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (18) :2325-2333
[4]   Screening for breast cancer: Recommendations and rationale [J].
Berg, AO ;
Allan, JD ;
Frame, PS ;
Homer, CJ ;
Johnson, MS ;
Klein, JD ;
Lieu, TA ;
Mulrow, CD ;
Orleans, CT ;
Peipert, JF ;
Pender, NJ ;
Siu, AL ;
Teutsch, SM ;
Westhoff, C ;
Woolf, SH .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (05) :344-346
[5]   The use of mammography by women aged 75 and older: Factors related to health, functioning, and age [J].
Blustein, J ;
Weiss, LJ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (08) :941-946
[6]   Health status and mammography use among older women [J].
Burack, RC ;
Gurney, JG ;
McDaniel, AM .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1998, 13 (06) :366-372
[7]   Black women receive less mammography even with similar use of primary care [J].
Burns, RB ;
McCarthy, EP ;
Freund, KM ;
Marwill, SL ;
Shwartz, M ;
Ash, A ;
Moskowitz, MA .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (03) :173-+
[8]  
Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008
[9]   RELATIONSHIP OF AGE TO MAMMOGRAPHY COMPLIANCE [J].
CHAMPION, V .
CANCER, 1994, 74 (01) :329-335
[10]   How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review [J].
Chow, E ;
Harth, T ;
Hruby, G ;
Finkelstein, J ;
Wu, J ;
Danjoux, C .
CLINICAL ONCOLOGY, 2001, 13 (03) :209-218